An Act to Expand Testing for Perfluoroalkyl and Polyfluoroalkyl Substances to Private Drinking Water Wells
Summary
LD 493 expands Maine’s drinking-water testing framework to explicitly include perfluoroalkyl and polyfluoroalkyl substances (PFAS) in the state’s recommended list of contaminants for periodic testing of residential private wells. The bill directs the Department of Health and Human Services to maintain a uniform testing recommendation for private drinking water wells and to include PFAS, along with other contaminants such as arsenic, bacteria, nitrates, lead, uranium, fluoride, and radon, unless the department determines testing is unnecessary based on prior results or credible scientific evidence. It also requires the department and any entity that provides well-testing information or advertising to include that recommendation in written materials.
Impact
The bill amends Maine law governing private well testing, landlord obligations, and real estate disclosure. It updates the landlord well-water testing statute so that landlords of residential buildings served by private wells must test not only for arsenic but also for other contaminants identified in the state’s uniform recommendation, and it separately adds a new requirement that landlords test for PFAS by January 1, 2027 using certified laboratories and EPA-approved analytical methods. The bill also expands seller disclosure requirements to include whether a seller has experienced a water test detecting PFAS, and it appropriates General Fund money to the Department of Health and Human Services for brochures, rulemaking, outreach, education, and one additional Environmental Specialist III position.
Sentiment
The voting history suggests the bill had majority support but was not unanimous, passing the House and Senate with moderate margins and later receiving enactment approval. The overall tone appears favorable toward expanding public-health protections for private well users, especially in light of PFAS concerns, with lawmakers willing to fund implementation and outreach. The absence of committee transcript discussion limits insight into detailed debate, but the recorded votes indicate the measure was generally accepted as a public-health and consumer-information bill.
Contention
The main likely points of contention are the added compliance costs and administrative burden on landlords, the expanded disclosure obligations for sellers, and the state funding required to implement the new testing and outreach requirements. Supporters would emphasize early detection of PFAS and other contaminants in private wells, while opponents or skeptics may focus on the cost of testing, the timing of the mandate, and whether the state should impose additional requirements on private property owners and landlords. The split votes suggest some disagreement over the breadth of the mandate and the appropriations needed to carry it out.